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Abstract 
Background: The acute respiratory distress syndrome (ARDS) is a life‑threatening condition. In special situations, 
these critically ill patients must be transferred to specialized centers for escalating treatment. The aim of this study was 
to evaluate the quality of inter‑hospital transport (IHT) of ARDS patients.
Methods: We evaluated medical and organizational aspects of structural and procedural quality relating to IHT of 
patients with ARDS in a prospective nationwide ARDS study. The qualification of emergency staff, the organizational 
aspects and the occurrence of critical events during transport were analyzed.
Results: Out of 1234 ARDS patients, 431 (34.9%) were transported, and 52 of these (12.1%) treated with extracorpor‑
eal membrane oxygenation. 63.1% of transferred patients were male, median age was 54 years, and 26.8% of patients 
were obese. All patients were mechanically ventilated during IHT. Pressure‑controlled ventilation was the preferred 
mode (92.1%). Median duration to organize the IHT was 165 min. Median distance for IHT was 58 km, and median 
duration of IHT 60 min. Forty‑two patient‑related and 8 technology‑related critical events (11.6%, 50 of 431 patients) 
were observed. When a critical event occurred, the  PaO2/FiO2 ratio before transport was significant lower (68 vs. 
80 mmHg, p = 0.017). 69.8% of physicians and 86.7% of paramedics confirmed all transfer qualifications according to 
requirements of the German faculty guidelines (DIVI).
Conclusions: The transport of critically ill patients is associated with potential risks. In our study the rate of patient‑ 
and technology‑related critical events was relatively low. A severe ARDS with a  PaO2/FiO2 ratio < 70 mmHg seems to 
be a risk factor for the appearance of critical events during IHT. The majority of transport staff was well qualified. Time 
span for organization of IHT was relatively short. ECMO is an option to transport patients with a severe ARDS safely to 
specialized centers.
Trial registration NCT02637011 (ClinicalTrials.gov, Registered 15 December 2015, retrospectively registered)
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Background
The acute respiratory distress syndrome (ARDS) is a life-
threatening condition characterized by either direct or 
indirect damage to the lung parenchyma often causing 
critical hypoxemia and/or hypercapnia [1]. The mortal-
ity for ARDS remains high between 30 and 60% despite 
all the progress made in intensive care during the last 
decades [2, 3]. The management of this severe disease at 
specialized intensive care units (ICU) is a resource-con-
suming process that requires a specially qualified team, 
a high-technology standard and sophisticated treat-
ment strategies to provide life-sustaining therapy [4]. 
Healthcare research in the field of critical care medicine 
is relatively new, and data on the influence of organiza-
tional structures or processes of care on mortality or 
health-related quality of life (HRQoL) in ICU survivors 
are of growing interest [5, 6]. Not all of these critically ill 
patients with an ARDS are treated primarily in a special-
ized center and, thus, eventually experience inter-hospi-
tal transfer (IHT).
In Germany, the frequency of IHT has grown consider-
ably in recent years and will steadily increase as a result 
of the expansion of specialized centers. For example, in 
the southwestern part of Germany the number of IHTs 
rose by 9.4% from 2014 to 2015 [7]. As a consequence, 
the health expenditures for patient transports were 
increased each year and for Germany overall costs rose to 
5.94 million Euros in 2013 [8].
The IHT is a secondary transport from one institution 
of initial or standard care for further therapy to an insti-
tution of advanced and/or maximum care, while main-
taining the intensive medical therapy already in progress 
[9, 10]. In this context, the IHT is synonymous with the 
term intensive care transport. The decision to trans-
port an ARDS patient is based on an assessment of the 
potential benefits of transport weighed against the poten-
tial risks. The transport must be as safe as possible and 
should not pose additional risks.
In Germany, IHT is conducted regularly by the author-
ized organizations of the Emergency Medical Services 
(EMS) coordinated by the local Emergency Medical Dis-
patch Center (EMDC). Standard EMS vehicles do not 
provide special intensive care equipment. ARDS patients 
require continuous monitoring and expanded intensive 
medical equipment (e.g., for lung-protective mechanical 
ventilation) and accordingly staff trained in intensive care 
medicine. These critically ill patients should be trans-
ferred with special vehicles such as intensive care ambu-
lances (ICA) or intensive care helicopters (ICH).
In this study, we assessed the quality of IHT in trans-
port survivor patients suffering from ARDS referred 
to specialized centers in a Germany-wide multicenter 
study. In addition to the means of transport used and the 
transport duration, the qualification of transportation 
personnel, technical equipment, ventilation parameters 
and the incidence of critical events were recorded.
Methods
Study design and sample
We observed the quality of IHT in patients with an ARDS 
in the context of a large Germany-wide prospective 
cohort study (DACOPO study [11], ClinicalTrials.gov 
Identifier: NCT02637011). Briefly, the DACAPO study 
investigates the influence of quality of care and indi-
vidual patient characteristics on HRQoL and return to 
work in survivors of ARDS. The study has been approved 
by the Ethics Committee of the University of Regens-
burg (original approval: December 2013, approval of an 
amendment: June 2014; file number 13-101-0262) and 
(if necessary) by Ethics Committees of the participating 
study centers. The inclusion criteria for enrollment of 
patients were the presence of an ARDS according to the 
Berlin definition [12] and being 18 years of age or older. 
Written informed consent was obtained from caregivers/
legal guardians and additionally from those patients who 
survived ICU. ARDS patients were included in the study 
after admittance to one of the participating hospitals, and 
data on transport were collected retrospectively. Mor-
tality during transportation could thus not be analyzed. 
Eligible patients were enrolled in 34 receiving hospitals 
all over Germany in the period from September 2014 to 
April 2016 (N = 1234). The health status of all transferred 
patients who had been treated before in a referring hos-
pital was retrospectively assessed for the period of their 
stay in this hospital and for the period during inter-hos-
pital transport. In the following, the examined aspects 
of the structural-, process- and outcome-related quality 
with regard to IHT are explained.
Measures
Sociodemographic and clinical parameters
The following sociodemographic and clinical parameters 
were assessed: age, body mass index (BMI), distribution 
of severity of ARDS, cause of ARDS, applied oxygen frac-
tion  (FiO2), positive end-expiratory pressure (PEEP), 
concentration of applied continuous infusion of norepi-
nephrine (noradrenalin), sequential organ failure assess-
ment (SOFA), use and duration for implementation of 
extracorporeal membrane oxygenation (ECMO) and type 
of used respirator. The clinical parameters of patients 
before transport were stated in the morning of the trans-
portation day.
Structural quality of IHT
The structural quality of IHT can be determined on the 
basis of technical and human resources. In Germany, 
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technical equipment of rescue vehicles is standardized 
by Germany’s national standards body (DIN norms) and 
European Committee for Standardization (CEN norms), 
respectively. The qualification of the EMS staff for IHT 
is recommended by the provisions of the German Inter-
disciplinary Association of Critical and Emergency Care 
Medicine (DIVI: Deutsche Interdisziplinäre Vereinigung 
für Intensiv- und Notfallmedizin) and German Confed-
eration of Associations of Emergency Physicians (BAND 
e.V.: Bundesvereinigung der Arbeitsgemeinschaften der 
Notärzte Deutschlands e.V.) [13].
Technical equipment of  EMS vehicles For transporting 
patients, specific standards are required. Three types of 
ambulances for the ground-based EMS vehicles with a 
minimum of technology standard are available in accord-
ance with CEN 1789:2014-12:
  • Type A: Patient Transport Ambulance
  • Type B: Emergency Ambulance
  • Type C: Mobile Intensive Care Unit
In addition, the German EMS is equipped with a limited 
number of specialized ICA, which is designated for IHT 
of critically ill patients. The specifications for ICA are 
described in DIN 75076:2012-05.
For the airborne transportation of patients, emergency 
helicopters or ICH are available. The technical standards 
of medical helicopters are normed by CEN 13718-1:2014 
(Medical vehicles and their equipment—Air ambu-
lances—Part 1: Requirements for medical devices used in 
air ambulances) and CEN 13718-2:2015 (Medical vehicles 
and their equipment—Air ambulances—Part 2: Opera-
tional and technical requirements for air ambulances). In 
Germany, some helicopters are dedicated to dual use, i.e., 
these air ambulances can be used in the regular EMS as 
well as in intensive care transport [14].
Based on these standards, we assessed the following 
items (yes/no): type of EMS vehicles and problems with 
technical equipment.
Qualification of  transportation staff For the escorting 
physician, we assessed the following items (yes/no), based 
on DIVI recommendations [13, 14]:
1. Three years of clinical training in a field with inten-
sive care tasks,
2. Six months verifiable full-time on an ICU,
3. Qualification as a pre-hospital emergency physician 
in the EMS according to local regulations,
4. Attending a 20-h course “intensive care transporta-
tion”
Due to the specific requirements of intensive care trans-
ports, the responsible paramedic also must have an addi-
tional qualification [13]. We assessed the following items 
(yes/no):
1. Professional qualification: paramedic
2. At least 3 years in an emergency service in a full-time 
or a time comparable to professional experience
3. Attending a 20-h course “intensive transport for 
emergency services personnel”
Process quality of IHT
The planned and used EMS vehicle, the IHT distance, the 
duration of the planning of IHT and the actually required 
duration of IHT were recorded using a specific case 
report form during patient admission in the receiving 
hospital and were extracted from the DIVI transport pro-
tocols [15, 16]. The communication between the referring 
and receiving hospital and between referring and trans-
port physician was also registered. In the planning of the 
study, we decided not to register respirator settings (tidal 
volume, breathing frequency) or lung-protective ventila-
tion, because these parameters were too variable and not 
documented in a standardized manner.
Outcome‑related quality of IHT
Changes in oxygenation  (PaO2/FiO2) and critical events 
(cardiopulmonary resuscitation, accidental extubation, 
hypoxia, and hypotension) were considered indicators of 
the outcome-associated qualities during IHT.
Data collection
The clinical data from the referring clinics were recorded 
by means of a fax request. Furthermore, communication 
between physicians of the referring and receiving hospi-
tals was registered. For each transferred patient, 220 up 
to 295 items were collected from study participants in the 
receiving hospitals. The collected data were transferred 
to the online documentation system  (OpenClinica®) 
as comprehensive as possible. In addition, the receiving 
physicians recorded whether an ARDS was overlooked in 
patients who were transferred.
Statistical analysis
Extensive plausibility tests were performed to ensure data 
quality. Due to the explorative character of this study, 
imputation methods are not appropriate. Thus, the sta-
tistical analyses are based on complete data for each 
parameter. Descriptive statistics were performed by cal-
culating median (Md) and inter-quartile range (IQR) for 
continuous variables. Counts and percentages were cal-
culated for categorical variables. For inference statistical 
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analyses regarding central tendency, Wilcoxon signed-
rank test (dependent samples) and the Mann–Whitney U 
test (independent samples) were carried out. In the case 
of categorial data, Fisher’s exact test was used. All tests 
are two-tailed. The significance level was set at p < 0.05. 
Analyses were computed using IBM SPSS Statistics (ver-
sion 24).
Results
A total of 431 patients with an ARDS were transferred 
from 315 different referring hospitals into 34 differ-
ent receiving hospitals. Twenty-nine of these 34 hospi-
tals (85%) are members of the German ARDS network. 
The median treatment time was 4 days (IQR 2–8) in the 
primary hospital before transportation. In median, six 
ARDS patients from five different hospitals were trans-
ferred per receiving hospital. In addition, the physicians 
of the receiving hospitals registered in 49 cases that the 
ARDS has been overlooked in the referring clinic in 
terms of a missing diagnosis. These 49 cases could not be 
included in the analysis.
Sociodemographic and clinical parameters
The median age of ARDS patients was 54  years (IQR 
43.0–64.0). 272 of the patients (63.1%) were male. In 
84%, direct pulmonary injury was the cause of ARDS. 
This ARDS cohort had a median BMI of 27.8 kg/m2 (IQR 
24.7–33.4), and 26.8% were obese with BMI  ≥  30  kg/
m2. The patients’ clinical characteristics before and after 
transportation are shown in Table 1. Particularly, patients 
with a moderate or severe ARDS were transported. The 
dose of noradrenalin infusion was stable during the IHT. 
All patients were mechanically ventilated during trans-
port, predominantly in a pressure-controlled manner 
(81.3% biphasic positive airway pressure [BIPAP], 10.8% 
pressure control ventilation [PCV]). The types of respira-
tors used were heterogeneous: the Oxylog 3000 plus (Fa. 
Dräger®) was most frequently mentioned (39%). The ven-
tilation of the ARDS patients during transport was per-
formed with a median positive end-expiratory pressure 
(PEEP) of 15 cm  H2O under applied  FiO2 of 0.9 (median). 
In total, 52 patients (12.3%) with median age of 52.5 years 
were transferred while being treated with ECMO. The 
implantation of ECMO was carried out in the referring 
hospital (median 60  min before IHT) by specialized 
ECMO teams.
Structural quality of IHT
Technology‑related problems of EMS vehicles
In our study, we observed eight technology-related prob-
lems. Equipment problems comprised especially the res-
pirator and syringe pump. In three cases a change in EMS 
vehicle was necessary (Table 2).
Qualification of transportation staff
The qualification of the transportation staff according to 
the requirements of the DIVI is summarized in Table 3. 
All transport teams included a physician. Nearly three-
quarter of the physicians attended the intensive transport 
course.
Process quality of IHT
Transport characteristics
The median time interval for inter-hospital transport 
of ARDS patients between request of the referring doc-
tor to the local EMDC and the start of the patient trans-
port was 165  min (IQR 90–290  min). The median time 
span to organize the IHT was 180 min for airborne and 
160 min for ground-based transportation. There were no 
significant differences in patient characteristics between 
Table 1 Patient characteristics before and after transport (Wilcoxon test)
a In the morning of the transportation day
b Immediately after ICU admission in the receiving hospital
* p < 0.05
Before  transporta After  transportb p value
ARDS severity (n = 295) (according to Berlin definition)
 Mild (n/%) 4/1.3 13/4.4
 Moderate (n/%) 69/23.4 97/32.9
 Severe (n/%) 222/75.3 185/62.7
SOFA score (n = 147) median (IQR) 10 (8–12) 11 (8–13) < 0.001*
PaO2/FiO2 (mmHg)
 All patients (n = 293) median (IQR) 78.8 (62.9–100) 82.9 (64.6–121.9) 0.002*
 Without ECMO (n = 251) median (IQR) 80.0 (63.3–101.3) 81.5 (63.8–115.1) 0.059
 With ECMO (n = 42) median (IQR) 72.5 (54.1–92.1) 95.6 (67.9–131.7) 0.002*
Continuous infusion of noradrenalin
(µg/kg/min) (n = 173) median (IQR)
0.22 (0.10–0.59) 0.24 (0.11–0.59) 0.388
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ground-based and airborne transportation. Over two-
thirds of the ARDS patients were transported on the 
ground; in nearly one-third of all patients an airborne 
transport was operated. The median distance between 
the referring and receiving hospitals was 58  km (IQR 
23–105 km), and the median transport time was 60 min 
(IQR 40–90 min). The median duration of transport for 
patients using ECMO was also 60 min. The median dis-
tance and duration for ground-based transportation were 
37 km in 60 min compared to 99 km in 54 min for air-
borne transport. Table 4 compares the transport vehicle 
requested by the referring institution and the ones actu-
ally used. No patient was transferred by EMS vehicle 
Type A. Transportation delays were caused by weather- 
and staff-related problems.
Communication
In 99% (388 of 392 cases, 39 missing data) of transfers, 
direct communication took place between the referring 
and receiving hospitals. In four cases the receiving hos-
pital was not aware of the patient allocation before the 
beginning of IHT. A structured conversation about the 
patient’s condition between referring and transport phy-
sician took place in 99.1% (345 of 348 cases, 83 missing 
data).
Outcome quality of IHT
For all patients who oxygenation data were available, the 
median  PaO2/FiO2 ratio was significantly better after IHT 
(p =  0.002) (Table  1). This applies also to patients with 
ECMO (p = 0.002). Patients with ECMO tended to have a 
better  PaO2/FiO2 ratio after transport than patients with-
out ECMO. A change in the severity of ARDS before and 
after transport was observed in 76 patients. After trans-
portation only 62.7% had an ARDS classified as “severe” 
as compared to 75.3% before transportation (Table  1). 
During transport, 42 patient-related and 8 technology-
related critical events (11.6%, 50/431 patients) were 
observed (Table 2). Neither the qualification of the trans-
portation staff nor the used transport vehicle was asso-
ciated with the occurrence of critical events (p =  0.14). 
However, the median  PaO2/FiO2 ratio before transport 
was significantly lower in patients who experienced a 
critical event during the transport (Md = 68 mmHg vs. 
Md = 80 mmHg, p = 0.017). The occurrence of hypoxia 
during IHT (n = 30) was lower in patients under ECMO 
Table 2 Frequency of critical events in 431 observed 
patients
a Survey of transport physician by receiving physician
Critical events Total (n)
Patient‑related
 Cardiopulmonary resuscitation 3
 Accidental extubation 2
 Hypoxia  (SpO2 < 85% over at least 5 min) 30
 Hypotension (systolic blood pressure < 80 mmHg over at 
least 5 min)
7
Technology‑related
 Equipment problems (thereof: respirator/syringe pump/
others)
5 (3/1/1)
 Transportation vehicle change necessary 3
Transportation delay
 Occurred transportation  delaya (thereof: weather‑/staff‑
related problems/others)
9 (3/1/5)
Table 3 Qualification of transportation staff
Qualification of transportation staff Results n 
(%)
Unknown/
missing n
Transport physician
 3 years of clinical training in a field with 
intensive care tasks with additional 
6 months verifiable full‑time in an ICU
256 of 279
(91.8)
152
 Qualification as an EMS physician (accord‑
ing to local regulations)
226 of 237
(95.4)
194
 20‑h course “intensive transportation” 131 of 179
(73.2)
252
  → All DIVI qualifications 125 of 179
(69.8)
252
Paramedic
 ≥3 years in an emergency service in a full‑
time or a time comparable to professional 
experience
188 of 190
(99.0)
241
 20‑h course “intensive transport for emer‑
gency services personnel”
144 of 166
(86.7)
265
  → All DIVI qualifications 144 of 166
(86.7)
265
Table 4 Characteristics of rescue transport vehicle used (requested and actually used)
Transport vehicle By referring hospital requested vehicle n (%) Used vehicle n (%)
Emergency helicopter/Intensive care helicopter 120 (35.7) 115 (32.2)
Intensive care ambulance 177 (52.7) 191 (53.5)
Emergency ambulance (type B/C CEN 1789:2014) 39 (11.6) 51 (14.3)
Total 336 (100) 357 (100)
Unknown/missing 95 of 431 (22.0) 74 of 431 (17.2)
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compared to patients without ECMO [3.8% (2 of 52 
cases) vs. 7.4% (28 of 379 cases)].
Discussion
This is the first study reporting data from a large number 
of ARDS patients, who had to be transferred predomi-
nantly to specialized hospitals in Germany. The IHT data 
of 431 patients were investigated prospectively.
The main results of our study are: (1) in most cases 
transport of ARDS patients was safe and without serious 
organ failure; (2) process quality for IHT organization: 
the elapsed time between the request and the departure 
of the transport was relatively short (Md  =  165  min), 
median duration of transport was 60  min, 68% ground-
based transport; (3) sufficient quality of outcome: criti-
cal events were rare, no deterioration of gas exchange, 
no change in concentration of infused catecholamine; (4) 
good structural quality: the majority of the IHT staff pos-
sessed specific qualifications.
The severity of hypoxemia  (PaO2/FiO2 
ratio ≤ 100 mmHg) is an important predictor for mortal-
ity in ARDS patients [12], and hypoxemia is one of the 
reasons to transfer a patient into a specialized center. 
In this study the majority of ARDS patients (85%) were 
transported to ARDS/ECMO centers for further treat-
ment. Patients with a severe ARDS and potentially 
reversible respiratory failure may have a better chance to 
survive when transported to an ECMO center [17–19].
Warren et  al. [20] claimed in their guidelines that all 
critical care transports ideally should be performed by 
specially trained professionals and the development of 
ECMO retrieval teams may lead to a safer transport of 
ARDS patients to tertiary care centers [21]. In this study 
the qualification of the transportation staff according to 
the requirements of the DIVI and BAND was respecta-
ble, but physician’s participation on DIVI intensive trans-
portation courses might be improved.
In a populous country like Germany, ARDS patients 
were transferred in a median of 60  min over a distance 
of 58 km. In our study, patients were transported mainly 
earth-bound. The airborne transportation of ARDS 
patients seems to be faster over longer transport distance, 
but the time span for organization was longer. The use of 
ECMO during the transport showed no relevant influ-
ence on the duration of transport. In a US study in the 
State of New York, 17 patients with ECMO were trans-
ported in 60  min over a mean distance of 37  km [22]. 
An Italian mobile ECMO team in Monza transferred 42 
patients over 121 km in a mean mission time of 508 min 
[21]. A Canadian study showed no influence of transport 
times on hospital mortality [23].
The ventilation settings during IHT could have an 
influence on patients’ outcome. ARDS patients receiving 
higher PEEP levels (mean difference of at least 3 cm  H2O 
between groups) had a trend toward improved survival 
[24]. But high PEEP can conceivably cause ventilator-
induced lung injury, pneumothorax or decreased car-
diac output. In our study, an oxygen fraction of 0.9 was 
chosen by the majority presumably to avoid hypoxemia 
during IHT. PCV for ARDS patients is associated with 
lower peak airway pressures, a more homogeneous gas 
distribution, improved patient-ventilator synchrony and 
earlier liberation from mechanical ventilation compared 
to volume-controlled ventilation [25, 26]. The use of PCV 
combined with adequate median PEEP of 15 mbar seems 
to be an indicator for a good quality of care during IHT.
ECMO treatment for transportation of severely 
hypoxic patients may allow safe and controlled transport 
to maximum care institutions. Isgrò et al. [27] showed in 
a 5-year report of 12 Italian patients with severe ARDS 
that ECMO effectively enabled high-risk ground trans-
fer, significantly improved the arterial oxygenation and 
allowed a protective lung ventilation. In a Korean study, 
18 patients with ECMO therapy were transferred without 
ventilation to a specialized center [28]. In our study in 
52 patients with severe ARDS ECMO cannulations were 
performed by specialized teams in the referral hospitals 
and they were transported to receiving hospitals.
Nevertheless, the transport of critically ill patients 
remains risky. A large Canadian study [29] as well as 
Rosenberg et al. [30] showed for critically ill transported 
patients an increased odds ratio of ICU death relative 
to patients admitted directly to ICU from the emer-
gency room. In the CESAR trial [31], 81 patients from 
the ECMO group were transported on mechanical ven-
tilation and 2 of these patients (2.4%) died during trans-
port. In our study we observed 42 patient-related and 8 
technology-related critical events (11.8%). This incidence 
might be relatively low, especially considering the possi-
bility of transfer to specialized ARDS centers. Addition-
ally in another study the rate of adverse events during 
IHT was reported to be low [32]. In the Netherlands the 
use of a specialist retrieval team reduced the occurrence 
of adverse events from 34 to 12.5% [33]. Nevertheless, a 
severe ARDS with a  PaO2/FiO2 ratio < 70 mmHg is asso-
ciated with an elevated risk for the appearance of critical 
events during IHT.
Strengths and limitations
Our study has some limitations. First, in patients, where 
an existing ARDS was not diagnosed by referring hos-
pital, no information was available about the quality of 
transport. The IHT data were collected Germany-wide 
by different investigators. Unfortunately, we lack infor-
mation about the type of ECMO (veno-venous, veno-
arterial). Furthermore, due to the complex procedures 
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of obtaining written informed consent, we could only 
include ARDS patients after transportation to the partici-
pating hospitals of the DACAPO study.
The strengths of our study are: a pre-specified protocol 
and case report forms, data collection in several centers 
across Germany, all elements of quality (structure-, pro-
cess-, outcome-associated) were assessed.
Conclusion
The transport of critically ill patients is associated with 
certain risks. The majority of transport staff in our study 
was well qualified. The rate of patient- and technology-
related critical events was relatively low. The time span 
between the initiation of the transfer procedure and the 
realization was good and better than expected. Our data 
suggest that ECMO is an option to transport patients 
with a severe ARDS safely to specialized ECMO centers, 
ideally by trained retrieval teams.
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